il-1

  1. Chandelier

    Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature, 2026, Muñoz-López et al.

    Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature Abstract Long COVID (LC) is characterized by persistent and, often, disabling symptoms, yet its biological basis remains unclear. Multiple mechanisms, including immune dysregulation, endothelial...
  2. SNT Gatchaman

    Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection, 2026, Fineschi, Bergquist+

    Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection Plasma proteomic profiling of 92 individuals with Post-Acute Sequelae of SARS-CoV-2 infection (PASC), assessed a mean of 34 months after acute infection, revealed a distinct...
  3. SNT Gatchaman

    Extracellular Vesicle-Delivered tRF-His-GTG-1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID-19, 2026, Liao et al.

    Extracellular Vesicle-Delivered tRF-His-GTG-1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID-19 Immunometabolism and neutrophil extracellular traps (NETs) play pivotal roles in the pathogenesis of coronavirus disease 2019 (COVID-19) and its postacute sequelae. However, the...
  4. SNT Gatchaman

    Long-term immune and epigenetic dysregulation following COVID-19, 2026, Sidiropoulou et al.

    Long-term immune and epigenetic dysregulation following COVID-19 Post-Acute COVID-19 syndrome (PACS) is heterogeneous in phenotype and functional state. This prospective, observational study studied adults six months after acute COVID-19. We defined clinical phenotypes and profiled plasma...
Back
Top Bottom